Dispensing Patterns of Blood Pressure Lowering Agents in Older Australians From 2006 to 2016

Si Si, Richard Ofori-Asenso, Tom Briffa, Jenni Ilomaki, Frank Sanfilippo, Christopher M. Reid, Danny Liew

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Background: Increasing numbers of blood pressure lowering (BPL) agents are being prescribed for both primary and secondary prevention of cardiovascular disease, especially in the older population. The aim of this study is to describe the temporal trends and patterns of BPL dispensing among older Australians (aged ≥65 years). Methods: We utilized prescription claims data from the Australian Pharmaceutical Benefits Scheme (PBS) for a 10% random sample of people aged ≥65 years. The PBS, funded by the Federal government, provides subsidies to make medicines more affordable for Australian residents. We restricted our analysis to “long-term concession” individuals, who would use PBS for the majority of their medication needs. BPL agents were identified using the World Health Organization Anatomical Therapeutic Chemical classification codes. The annual prevalences and proportional distributions of BPL dispensing by categories were summarized from 2006 to 2016. Direct standardization was applied to indicate changes of BPL dispensing over time. Results: Age-standardized dispensing of BPL agents increased by 8% among older Australians from 2006 to 2016 (58%-66%). BPL dispensing in males has exceeded that in females since 2009. Angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers were the dominant BPL agents dispensed, with more than 55% of all BPL users over time. Dispensing of diuretics decreased from 27% to 21%, calcium channel blockers decreased from 30% to 25%, while β-blockers remained stable (29%-31%). The use of fixed-dose combinations increased over time from 23% to 31%. Conclusion: The prevalence of BPL dispensing steadily increased among older Australians from 2006 to 2016. The changes in the patterns of BPL dispensing were largely in line with contemporary changes to clinical guidelines for an aging population.

Original languageEnglish
Pages (from-to)242-250
Number of pages9
JournalJournal of Cardiovascular Pharmacology and Therapeutics
Volume24
Issue number3
DOIs
Publication statusPublished - May 2019

Keywords

  • Australia
  • blood pressure lowering agents
  • medication dispensing
  • older population

Cite this

@article{e077db3874de4a5f9c1979184862249d,
title = "Dispensing Patterns of Blood Pressure Lowering Agents in Older Australians From 2006 to 2016",
abstract = "Background: Increasing numbers of blood pressure lowering (BPL) agents are being prescribed for both primary and secondary prevention of cardiovascular disease, especially in the older population. The aim of this study is to describe the temporal trends and patterns of BPL dispensing among older Australians (aged ≥65 years). Methods: We utilized prescription claims data from the Australian Pharmaceutical Benefits Scheme (PBS) for a 10{\%} random sample of people aged ≥65 years. The PBS, funded by the Federal government, provides subsidies to make medicines more affordable for Australian residents. We restricted our analysis to “long-term concession” individuals, who would use PBS for the majority of their medication needs. BPL agents were identified using the World Health Organization Anatomical Therapeutic Chemical classification codes. The annual prevalences and proportional distributions of BPL dispensing by categories were summarized from 2006 to 2016. Direct standardization was applied to indicate changes of BPL dispensing over time. Results: Age-standardized dispensing of BPL agents increased by 8{\%} among older Australians from 2006 to 2016 (58{\%}-66{\%}). BPL dispensing in males has exceeded that in females since 2009. Angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers were the dominant BPL agents dispensed, with more than 55{\%} of all BPL users over time. Dispensing of diuretics decreased from 27{\%} to 21{\%}, calcium channel blockers decreased from 30{\%} to 25{\%}, while β-blockers remained stable (29{\%}-31{\%}). The use of fixed-dose combinations increased over time from 23{\%} to 31{\%}. Conclusion: The prevalence of BPL dispensing steadily increased among older Australians from 2006 to 2016. The changes in the patterns of BPL dispensing were largely in line with contemporary changes to clinical guidelines for an aging population.",
keywords = "Australia, blood pressure lowering agents, medication dispensing, older population",
author = "Si Si and Richard Ofori-Asenso and Tom Briffa and Jenni Ilomaki and Frank Sanfilippo and Reid, {Christopher M.} and Danny Liew",
year = "2019",
month = "5",
doi = "10.1177/1074248418812184",
language = "English",
volume = "24",
pages = "242--250",
journal = "Journal of Cardiovascular Pharmacology and Therapeutics",
issn = "1074-2484",
publisher = "SAGE Publications Ltd",
number = "3",

}

Dispensing Patterns of Blood Pressure Lowering Agents in Older Australians From 2006 to 2016. / Si, Si; Ofori-Asenso, Richard; Briffa, Tom; Ilomaki, Jenni; Sanfilippo, Frank; Reid, Christopher M.; Liew, Danny.

In: Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 24, No. 3, 05.2019, p. 242-250.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Dispensing Patterns of Blood Pressure Lowering Agents in Older Australians From 2006 to 2016

AU - Si, Si

AU - Ofori-Asenso, Richard

AU - Briffa, Tom

AU - Ilomaki, Jenni

AU - Sanfilippo, Frank

AU - Reid, Christopher M.

AU - Liew, Danny

PY - 2019/5

Y1 - 2019/5

N2 - Background: Increasing numbers of blood pressure lowering (BPL) agents are being prescribed for both primary and secondary prevention of cardiovascular disease, especially in the older population. The aim of this study is to describe the temporal trends and patterns of BPL dispensing among older Australians (aged ≥65 years). Methods: We utilized prescription claims data from the Australian Pharmaceutical Benefits Scheme (PBS) for a 10% random sample of people aged ≥65 years. The PBS, funded by the Federal government, provides subsidies to make medicines more affordable for Australian residents. We restricted our analysis to “long-term concession” individuals, who would use PBS for the majority of their medication needs. BPL agents were identified using the World Health Organization Anatomical Therapeutic Chemical classification codes. The annual prevalences and proportional distributions of BPL dispensing by categories were summarized from 2006 to 2016. Direct standardization was applied to indicate changes of BPL dispensing over time. Results: Age-standardized dispensing of BPL agents increased by 8% among older Australians from 2006 to 2016 (58%-66%). BPL dispensing in males has exceeded that in females since 2009. Angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers were the dominant BPL agents dispensed, with more than 55% of all BPL users over time. Dispensing of diuretics decreased from 27% to 21%, calcium channel blockers decreased from 30% to 25%, while β-blockers remained stable (29%-31%). The use of fixed-dose combinations increased over time from 23% to 31%. Conclusion: The prevalence of BPL dispensing steadily increased among older Australians from 2006 to 2016. The changes in the patterns of BPL dispensing were largely in line with contemporary changes to clinical guidelines for an aging population.

AB - Background: Increasing numbers of blood pressure lowering (BPL) agents are being prescribed for both primary and secondary prevention of cardiovascular disease, especially in the older population. The aim of this study is to describe the temporal trends and patterns of BPL dispensing among older Australians (aged ≥65 years). Methods: We utilized prescription claims data from the Australian Pharmaceutical Benefits Scheme (PBS) for a 10% random sample of people aged ≥65 years. The PBS, funded by the Federal government, provides subsidies to make medicines more affordable for Australian residents. We restricted our analysis to “long-term concession” individuals, who would use PBS for the majority of their medication needs. BPL agents were identified using the World Health Organization Anatomical Therapeutic Chemical classification codes. The annual prevalences and proportional distributions of BPL dispensing by categories were summarized from 2006 to 2016. Direct standardization was applied to indicate changes of BPL dispensing over time. Results: Age-standardized dispensing of BPL agents increased by 8% among older Australians from 2006 to 2016 (58%-66%). BPL dispensing in males has exceeded that in females since 2009. Angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers were the dominant BPL agents dispensed, with more than 55% of all BPL users over time. Dispensing of diuretics decreased from 27% to 21%, calcium channel blockers decreased from 30% to 25%, while β-blockers remained stable (29%-31%). The use of fixed-dose combinations increased over time from 23% to 31%. Conclusion: The prevalence of BPL dispensing steadily increased among older Australians from 2006 to 2016. The changes in the patterns of BPL dispensing were largely in line with contemporary changes to clinical guidelines for an aging population.

KW - Australia

KW - blood pressure lowering agents

KW - medication dispensing

KW - older population

UR - http://www.scopus.com/inward/record.url?scp=85059033762&partnerID=8YFLogxK

U2 - 10.1177/1074248418812184

DO - 10.1177/1074248418812184

M3 - Article

VL - 24

SP - 242

EP - 250

JO - Journal of Cardiovascular Pharmacology and Therapeutics

JF - Journal of Cardiovascular Pharmacology and Therapeutics

SN - 1074-2484

IS - 3

ER -